The burst of reprogramming technology in recent years has revolutionized the field of stem cell biology, offering new opportunities for personalized, regenerative therapies. The direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) has provided an invaluable tool to study and model a wide range of human diseases. Here, we review the transforming potential of such a strategy in research and in therapies applicable to the hematology field.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371872 | PMC |
| http://dx.doi.org/10.3390/cells6010007 | DOI Listing |
Publication Analysis
Top Keywords
induced pluripotent
8
pluripotent stem
8
stem cell
8
application induced
4
cell technology
4
technology study
4
study hematological
4
hematological diseases
4
diseases burst
4
burst reprogramming
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!